Liana Hakobyan

  • Citations Per Year
Learn More
BACKGROUND Non-serious symptomatic adverse drug events (ADEs) affect the real benefit-risk ratio of a drug. Currently, such ADEs are quantified in different ways, often using reports from a(More)
  • 1